Mohammad B Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammad B Khan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aizaz Chaudhary
Department of Neurology, Georgia Regents University, Augusta, GA 30912, USA
1 shared publication - David C. Hess
Georgia Regent’s University
1 shared publication - Jennifer L Waller
Department of Biostatistics and Epidemiology, Georgia Regents University, Augusta, GA 30912, USA
1 shared publication - Krishnan M. Dhandapani
Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
1 shared publication - Kumar Vaibhav
Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA
1 shared publication - Nasrul Hoda
Department of Neurology, Georgia Regents University, Augusta, GA, USA
1 shared publication
Latest Publications
- Open Access
- 9 October 2014
- Published by Springer Nature in Experimental & Translational Stroke Medicine
- Vol. 6 (1) , 10
A 2 × 2 factorial design for the combination therapy of minocycline and remote ischemic perconditioning: efficacy in a preclinical trial in murine thromboembolic stroke model
After the failure of so many drugs and therapies for acute ischemic stroke, innovative approaches are needed to develop new treatments. One promising strategy is to test combinations of agents in the pre-hospital setting prior to the administration of intravenous tissue plasminogen activator (IV-tPA) and/ or the use of mechanical reperfusion devices in the hospital.
- 9 October 2014
- Published by Springer Nature in Experimental & Translational Stroke Medicine
- Vol. 6 (1) , 10
Open AccessA 2 × 2 factorial design for the combination therapy of minocycline and remote ischemic perconditioning: efficacy in a preclinical trial in murine thromboembolic stroke model
After the failure of so many drugs and therapies for acute ischemic stroke, innovative approaches are needed to develop new treatments. One promising strategy is to test combinations of agents in the pre-hospital setting prior to the administration of intravenous tissue plasminogen activator (IV-tPA) and/ or the use of mechanical reperfusion devices in the hospital.